nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—Estropipate—osteoporosis	0.48	0.707	CbGbCtD
Cefotetan—ALB—Estradiol—osteoporosis	0.199	0.293	CbGbCtD
Cefotetan—Vaginal moniliasis—Estropipate—osteoporosis	0.00752	0.0242	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Estropipate—osteoporosis	0.00722	0.0232	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Estropipate—osteoporosis	0.00694	0.0223	CcSEcCtD
Cefotetan—Nephropathy toxic—Ibandronate—osteoporosis	0.00634	0.0204	CcSEcCtD
Cefotetan—Vaginal moniliasis—Conjugated Estrogens—osteoporosis	0.00497	0.016	CcSEcCtD
Cefotetan—Nephropathy toxic—Pamidronate—osteoporosis	0.00497	0.0159	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Conjugated Estrogens—osteoporosis	0.00477	0.0153	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Conjugated Estrogens—osteoporosis	0.00459	0.0147	CcSEcCtD
Cefotetan—Nephropathy toxic—Zoledronate—osteoporosis	0.00454	0.0146	CcSEcCtD
Cefotetan—Vaginal moniliasis—Estradiol—osteoporosis	0.00398	0.0128	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Estradiol—osteoporosis	0.00382	0.0123	CcSEcCtD
Cefotetan—Vaginal inflammation—Estropipate—osteoporosis	0.0038	0.0122	CcSEcCtD
Cefotetan—Vaginal inflammation—Raloxifene—osteoporosis	0.00368	0.0118	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Estradiol—osteoporosis	0.00367	0.0118	CcSEcCtD
Cefotetan—Vaginal inflammation—Ibandronate—osteoporosis	0.00364	0.0117	CcSEcCtD
Cefotetan—Vaginal infection—Estropipate—osteoporosis	0.00358	0.0115	CcSEcCtD
Cefotetan—Vaginal infection—Raloxifene—osteoporosis	0.00347	0.0111	CcSEcCtD
Cefotetan—Vaginal infection—Ibandronate—osteoporosis	0.00344	0.011	CcSEcCtD
Cefotetan—Hepatic function abnormal—Estropipate—osteoporosis	0.00315	0.0101	CcSEcCtD
Cefotetan—Vaginal inflammation—Ethinyl Estradiol—osteoporosis	0.00308	0.00988	CcSEcCtD
Cefotetan—Vaginal infection—Ethinyl Estradiol—osteoporosis	0.00291	0.00933	CcSEcCtD
Cefotetan—Colitis—Risedronate—osteoporosis	0.00288	0.00925	CcSEcCtD
Cefotetan—Pancytopenia—Etidronic acid—osteoporosis	0.00261	0.0084	CcSEcCtD
Cefotetan—Vaginal inflammation—Conjugated Estrogens—osteoporosis	0.00251	0.00805	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Alendronate—osteoporosis	0.00244	0.00785	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.00243	0.00781	CcSEcCtD
Cefotetan—Phlebitis—Pamidronate—osteoporosis	0.0024	0.00772	CcSEcCtD
Cefotetan—Hepatic function abnormal—Pamidronate—osteoporosis	0.00237	0.00761	CcSEcCtD
Cefotetan—Vaginal infection—Conjugated Estrogens—osteoporosis	0.00237	0.0076	CcSEcCtD
Cefotetan—Agranulocytosis—Etidronic acid—osteoporosis	0.00229	0.00736	CcSEcCtD
Cefotetan—Phlebitis—Conjugated Estrogens—osteoporosis	0.00211	0.00679	CcSEcCtD
Cefotetan—Erythema multiforme—Etidronic acid—osteoporosis	0.00208	0.00669	CcSEcCtD
Cefotetan—Hepatic function abnormal—Conjugated Estrogens—osteoporosis	0.00208	0.00669	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00207	0.00666	CcSEcCtD
Cefotetan—Vaginal inflammation—Estradiol—osteoporosis	0.00201	0.00645	CcSEcCtD
Cefotetan—Vaginal infection—Estradiol—osteoporosis	0.0019	0.00609	CcSEcCtD
Cefotetan—Haemoglobin—Alendronate—osteoporosis	0.00189	0.00606	CcSEcCtD
Cefotetan—Haemorrhage—Alendronate—osteoporosis	0.00188	0.00603	CcSEcCtD
Cefotetan—Haemoglobin—Ibandronate—osteoporosis	0.00184	0.0059	CcSEcCtD
Cefotetan—Haemorrhage—Ibandronate—osteoporosis	0.00183	0.00587	CcSEcCtD
Cefotetan—Erythema multiforme—Estropipate—osteoporosis	0.0018	0.00579	CcSEcCtD
Cefotetan—Haemoglobin—Calcitriol—osteoporosis	0.0018	0.00578	CcSEcCtD
Cefotetan—Haemorrhage—Calcitriol—osteoporosis	0.00179	0.00575	CcSEcCtD
Cefotetan—Erythema multiforme—Alendronate—osteoporosis	0.00178	0.0057	CcSEcCtD
Cefotetan—Hypersensitivity—Calcium Acetate—osteoporosis	0.00176	0.00564	CcSEcCtD
Cefotetan—Leukopenia—Etidronic acid—osteoporosis	0.00172	0.00551	CcSEcCtD
Cefotetan—Erythema multiforme—Calcitriol—osteoporosis	0.00169	0.00543	CcSEcCtD
Cefotetan—Phlebitis—Estradiol—osteoporosis	0.00169	0.00543	CcSEcCtD
Cefotetan—Pruritus—Calcium Acetate—osteoporosis	0.00169	0.00542	CcSEcCtD
Cefotetan—Neutropenia—Pamidronate—osteoporosis	0.00167	0.00537	CcSEcCtD
Cefotetan—Hepatic function abnormal—Estradiol—osteoporosis	0.00167	0.00535	CcSEcCtD
Cefotetan—Diarrhoea—Calcium Acetate—osteoporosis	0.00163	0.00524	CcSEcCtD
Cefotetan—Discomfort—Etidronic acid—osteoporosis	0.00161	0.00518	CcSEcCtD
Cefotetan—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00155	0.00499	CcSEcCtD
Cefotetan—Pancytopenia—Zoledronate—osteoporosis	0.00155	0.00498	CcSEcCtD
Cefotetan—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00155	0.00496	CcSEcCtD
Cefotetan—Neutropenia—Zoledronate—osteoporosis	0.00153	0.00491	CcSEcCtD
Cefotetan—Vomiting—Calcium Acetate—osteoporosis	0.00152	0.00487	CcSEcCtD
Cefotetan—Haemoglobin—Risedronate—osteoporosis	0.00151	0.00486	CcSEcCtD
Cefotetan—Haemorrhage—Risedronate—osteoporosis	0.00151	0.00484	CcSEcCtD
Cefotetan—Agranulocytosis—Pamidronate—osteoporosis	0.00149	0.00478	CcSEcCtD
Cefotetan—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00146	0.00469	CcSEcCtD
Cefotetan—Haemoglobin—Pamidronate—osteoporosis	0.00144	0.00462	CcSEcCtD
Cefotetan—Haemorrhage—Pamidronate—osteoporosis	0.00143	0.0046	CcSEcCtD
Cefotetan—Nausea—Calcium Acetate—osteoporosis	0.00142	0.00455	CcSEcCtD
Cefotetan—Discomfort—Alendronate—osteoporosis	0.00137	0.00441	CcSEcCtD
Cefotetan—Agranulocytosis—Zoledronate—osteoporosis	0.00136	0.00437	CcSEcCtD
Cefotetan—Anaphylactic shock—Estropipate—osteoporosis	0.00135	0.00435	CcSEcCtD
Cefotetan—Convulsion—Calcitriol—osteoporosis	0.00135	0.00433	CcSEcCtD
Cefotetan—Discomfort—Ibandronate—osteoporosis	0.00134	0.0043	CcSEcCtD
Cefotetan—Discomfort—Calcitriol—osteoporosis	0.00131	0.00421	CcSEcCtD
Cefotetan—Anaphylactic shock—Ibandronate—osteoporosis	0.0013	0.00417	CcSEcCtD
Cefotetan—Thrombocytopenia—Raloxifene—osteoporosis	0.00128	0.00412	CcSEcCtD
Cefotetan—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00128	0.00411	CcSEcCtD
Cefotetan—Anaphylactic shock—Calcitriol—osteoporosis	0.00127	0.00408	CcSEcCtD
Cefotetan—Nausea—Ergocalciferol—osteoporosis	0.00125	0.00402	CcSEcCtD
Cefotetan—Urticaria—Etidronic acid—osteoporosis	0.00124	0.00399	CcSEcCtD
Cefotetan—Abdominal pain—Etidronic acid—osteoporosis	0.00124	0.00397	CcSEcCtD
Cefotetan—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00119	0.00382	CcSEcCtD
Cefotetan—Hypersensitivity—Etidronic acid—osteoporosis	0.00115	0.0037	CcSEcCtD
Cefotetan—Discomfort—Ethinyl Estradiol—osteoporosis	0.00113	0.00363	CcSEcCtD
Cefotetan—Leukopenia—Pamidronate—osteoporosis	0.00112	0.00358	CcSEcCtD
Cefotetan—Pruritus—Etidronic acid—osteoporosis	0.00111	0.00356	CcSEcCtD
Cefotetan—Gastrointestinal pain—Estropipate—osteoporosis	0.00111	0.00356	CcSEcCtD
Cefotetan—Gastrointestinal pain—Alendronate—osteoporosis	0.00109	0.0035	CcSEcCtD
Cefotetan—Convulsion—Pamidronate—osteoporosis	0.00108	0.00347	CcSEcCtD
Cefotetan—Urticaria—Estropipate—osteoporosis	0.00108	0.00345	CcSEcCtD
Cefotetan—Gastrointestinal pain—Raloxifene—osteoporosis	0.00107	0.00344	CcSEcCtD
Cefotetan—Diarrhoea—Etidronic acid—osteoporosis	0.00107	0.00344	CcSEcCtD
Cefotetan—Abdominal pain—Estropipate—osteoporosis	0.00107	0.00344	CcSEcCtD
Cefotetan—Body temperature increased—Estropipate—osteoporosis	0.00107	0.00344	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ibandronate—osteoporosis	0.00106	0.00341	CcSEcCtD
Cefotetan—Urticaria—Alendronate—osteoporosis	0.00106	0.0034	CcSEcCtD
Cefotetan—Abdominal pain—Alendronate—osteoporosis	0.00105	0.00339	CcSEcCtD
Cefotetan—Body temperature increased—Alendronate—osteoporosis	0.00105	0.00339	CcSEcCtD
Cefotetan—Discomfort—Pamidronate—osteoporosis	0.00105	0.00337	CcSEcCtD
Cefotetan—Gastrointestinal pain—Calcitriol—osteoporosis	0.00104	0.00334	CcSEcCtD
Cefotetan—Body temperature increased—Raloxifene—osteoporosis	0.00104	0.00333	CcSEcCtD
Cefotetan—Abdominal pain—Raloxifene—osteoporosis	0.00104	0.00333	CcSEcCtD
Cefotetan—Urticaria—Ibandronate—osteoporosis	0.00103	0.00331	CcSEcCtD
Cefotetan—Body temperature increased—Ibandronate—osteoporosis	0.00103	0.0033	CcSEcCtD
Cefotetan—Abdominal pain—Ibandronate—osteoporosis	0.00103	0.0033	CcSEcCtD
Cefotetan—Leukopenia—Zoledronate—osteoporosis	0.00102	0.00327	CcSEcCtD
Cefotetan—Anaphylactic shock—Pamidronate—osteoporosis	0.00102	0.00327	CcSEcCtD
Cefotetan—Haemoglobin—Estradiol—osteoporosis	0.00101	0.00325	CcSEcCtD
Cefotetan—Urticaria—Calcitriol—osteoporosis	0.00101	0.00324	CcSEcCtD
Cefotetan—Haemorrhage—Estradiol—osteoporosis	0.00101	0.00324	CcSEcCtD
Cefotetan—Abdominal pain—Calcitriol—osteoporosis	0.00101	0.00323	CcSEcCtD
Cefotetan—Body temperature increased—Calcitriol—osteoporosis	0.00101	0.00323	CcSEcCtD
Cefotetan—Hypersensitivity—Estropipate—osteoporosis	0.000998	0.0032	CcSEcCtD
Cefotetan—Thrombocytopenia—Pamidronate—osteoporosis	0.000996	0.0032	CcSEcCtD
Cefotetan—Vomiting—Etidronic acid—osteoporosis	0.000995	0.0032	CcSEcCtD
Cefotetan—Rash—Etidronic acid—osteoporosis	0.000987	0.00317	CcSEcCtD
Cefotetan—Convulsion—Zoledronate—osteoporosis	0.000987	0.00317	CcSEcCtD
Cefotetan—Dermatitis—Etidronic acid—osteoporosis	0.000986	0.00317	CcSEcCtD
Cefotetan—Hypersensitivity—Alendronate—osteoporosis	0.000983	0.00316	CcSEcCtD
Cefotetan—Pruritus—Estropipate—osteoporosis	0.000958	0.00308	CcSEcCtD
Cefotetan—Discomfort—Zoledronate—osteoporosis	0.000958	0.00308	CcSEcCtD
Cefotetan—Hypersensitivity—Ibandronate—osteoporosis	0.000957	0.00307	CcSEcCtD
Cefotetan—Erythema multiforme—Estradiol—osteoporosis	0.000953	0.00306	CcSEcCtD
Cefotetan—Convulsion—Conjugated Estrogens—osteoporosis	0.00095	0.00305	CcSEcCtD
Cefotetan—Pruritus—Alendronate—osteoporosis	0.000944	0.00303	CcSEcCtD
Cefotetan—Hypersensitivity—Calcitriol—osteoporosis	0.000937	0.00301	CcSEcCtD
Cefotetan—Nausea—Etidronic acid—osteoporosis	0.00093	0.00299	CcSEcCtD
Cefotetan—Anaphylactic shock—Zoledronate—osteoporosis	0.000929	0.00298	CcSEcCtD
Cefotetan—Diarrhoea—Estropipate—osteoporosis	0.000927	0.00298	CcSEcCtD
Cefotetan—Pruritus—Ibandronate—osteoporosis	0.000919	0.00295	CcSEcCtD
Cefotetan—Diarrhoea—Alendronate—osteoporosis	0.000913	0.00293	CcSEcCtD
Cefotetan—Thrombocytopenia—Zoledronate—osteoporosis	0.00091	0.00292	CcSEcCtD
Cefotetan—Pruritus—Calcitriol—osteoporosis	0.0009	0.00289	CcSEcCtD
Cefotetan—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000898	0.00288	CcSEcCtD
Cefotetan—Diarrhoea—Raloxifene—osteoporosis	0.000898	0.00288	CcSEcCtD
Cefotetan—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000895	0.00287	CcSEcCtD
Cefotetan—Diarrhoea—Ibandronate—osteoporosis	0.000889	0.00285	CcSEcCtD
Cefotetan—Gastrointestinal pain—Risedronate—osteoporosis	0.000875	0.00281	CcSEcCtD
Cefotetan—Urticaria—Ethinyl Estradiol—osteoporosis	0.000872	0.0028	CcSEcCtD
Cefotetan—Diarrhoea—Calcitriol—osteoporosis	0.00087	0.00279	CcSEcCtD
Cefotetan—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000868	0.00279	CcSEcCtD
Cefotetan—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000868	0.00279	CcSEcCtD
Cefotetan—Vomiting—Estropipate—osteoporosis	0.000861	0.00277	CcSEcCtD
Cefotetan—Rash—Estropipate—osteoporosis	0.000854	0.00274	CcSEcCtD
Cefotetan—Dermatitis—Estropipate—osteoporosis	0.000853	0.00274	CcSEcCtD
Cefotetan—Urticaria—Risedronate—osteoporosis	0.00085	0.00273	CcSEcCtD
Cefotetan—Vomiting—Alendronate—osteoporosis	0.000848	0.00272	CcSEcCtD
Cefotetan—Body temperature increased—Risedronate—osteoporosis	0.000846	0.00272	CcSEcCtD
Cefotetan—Abdominal pain—Risedronate—osteoporosis	0.000846	0.00272	CcSEcCtD
Cefotetan—Rash—Alendronate—osteoporosis	0.000841	0.0027	CcSEcCtD
Cefotetan—Dermatitis—Alendronate—osteoporosis	0.00084	0.0027	CcSEcCtD
Cefotetan—Vomiting—Raloxifene—osteoporosis	0.000834	0.00268	CcSEcCtD
Cefotetan—Gastrointestinal pain—Pamidronate—osteoporosis	0.000832	0.00267	CcSEcCtD
Cefotetan—Rash—Raloxifene—osteoporosis	0.000827	0.00266	CcSEcCtD
Cefotetan—Dermatitis—Raloxifene—osteoporosis	0.000826	0.00265	CcSEcCtD
Cefotetan—Vomiting—Ibandronate—osteoporosis	0.000826	0.00265	CcSEcCtD
Cefotetan—Rash—Ibandronate—osteoporosis	0.000819	0.00263	CcSEcCtD
Cefotetan—Dermatitis—Ibandronate—osteoporosis	0.000818	0.00263	CcSEcCtD
Cefotetan—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000809	0.0026	CcSEcCtD
Cefotetan—Vomiting—Calcitriol—osteoporosis	0.000808	0.0026	CcSEcCtD
Cefotetan—Nausea—Estropipate—osteoporosis	0.000805	0.00258	CcSEcCtD
Cefotetan—Abdominal pain—Pamidronate—osteoporosis	0.000804	0.00258	CcSEcCtD
Cefotetan—Body temperature increased—Pamidronate—osteoporosis	0.000804	0.00258	CcSEcCtD
Cefotetan—Rash—Calcitriol—osteoporosis	0.000802	0.00257	CcSEcCtD
Cefotetan—Dermatitis—Calcitriol—osteoporosis	0.000801	0.00257	CcSEcCtD
Cefotetan—Nausea—Alendronate—osteoporosis	0.000792	0.00254	CcSEcCtD
Cefotetan—Hypersensitivity—Risedronate—osteoporosis	0.000789	0.00253	CcSEcCtD
Cefotetan—Nausea—Raloxifene—osteoporosis	0.000779	0.0025	CcSEcCtD
Cefotetan—Pruritus—Ethinyl Estradiol—osteoporosis	0.000777	0.00249	CcSEcCtD
Cefotetan—Nausea—Ibandronate—osteoporosis	0.000771	0.00248	CcSEcCtD
Cefotetan—Gastrointestinal pain—Zoledronate—osteoporosis	0.00076	0.00244	CcSEcCtD
Cefotetan—Pruritus—Risedronate—osteoporosis	0.000757	0.00243	CcSEcCtD
Cefotetan—Nausea—Calcitriol—osteoporosis	0.000755	0.00242	CcSEcCtD
Cefotetan—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000751	0.00241	CcSEcCtD
Cefotetan—Hypersensitivity—Pamidronate—osteoporosis	0.00075	0.00241	CcSEcCtD
Cefotetan—Urticaria—Zoledronate—osteoporosis	0.000738	0.00237	CcSEcCtD
Cefotetan—Discomfort—Estradiol—osteoporosis	0.000738	0.00237	CcSEcCtD
Cefotetan—Body temperature increased—Zoledronate—osteoporosis	0.000735	0.00236	CcSEcCtD
Cefotetan—Abdominal pain—Zoledronate—osteoporosis	0.000735	0.00236	CcSEcCtD
Cefotetan—Diarrhoea—Risedronate—osteoporosis	0.000732	0.00235	CcSEcCtD
Cefotetan—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000732	0.00235	CcSEcCtD
Cefotetan—Pruritus—Pamidronate—osteoporosis	0.00072	0.00231	CcSEcCtD
Cefotetan—Anaphylactic shock—Estradiol—osteoporosis	0.000716	0.0023	CcSEcCtD
Cefotetan—Urticaria—Conjugated Estrogens—osteoporosis	0.000711	0.00228	CcSEcCtD
Cefotetan—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000707	0.00227	CcSEcCtD
Cefotetan—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000707	0.00227	CcSEcCtD
Cefotetan—Vomiting—Ethinyl Estradiol—osteoporosis	0.000698	0.00224	CcSEcCtD
Cefotetan—Diarrhoea—Pamidronate—osteoporosis	0.000696	0.00224	CcSEcCtD
Cefotetan—Rash—Ethinyl Estradiol—osteoporosis	0.000692	0.00222	CcSEcCtD
Cefotetan—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000692	0.00222	CcSEcCtD
Cefotetan—Hypersensitivity—Zoledronate—osteoporosis	0.000685	0.0022	CcSEcCtD
Cefotetan—Vomiting—Risedronate—osteoporosis	0.000681	0.00219	CcSEcCtD
Cefotetan—Rash—Risedronate—osteoporosis	0.000675	0.00217	CcSEcCtD
Cefotetan—Dermatitis—Risedronate—osteoporosis	0.000674	0.00217	CcSEcCtD
Cefotetan—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000659	0.00212	CcSEcCtD
Cefotetan—Pruritus—Zoledronate—osteoporosis	0.000658	0.00211	CcSEcCtD
Cefotetan—Nausea—Ethinyl Estradiol—osteoporosis	0.000652	0.00209	CcSEcCtD
Cefotetan—Vomiting—Pamidronate—osteoporosis	0.000647	0.00208	CcSEcCtD
Cefotetan—Rash—Pamidronate—osteoporosis	0.000642	0.00206	CcSEcCtD
Cefotetan—Dermatitis—Pamidronate—osteoporosis	0.000641	0.00206	CcSEcCtD
Cefotetan—Diarrhoea—Zoledronate—osteoporosis	0.000636	0.00204	CcSEcCtD
Cefotetan—Nausea—Risedronate—osteoporosis	0.000636	0.00204	CcSEcCtD
Cefotetan—Pruritus—Conjugated Estrogens—osteoporosis	0.000633	0.00203	CcSEcCtD
Cefotetan—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000612	0.00197	CcSEcCtD
Cefotetan—Nausea—Pamidronate—osteoporosis	0.000604	0.00194	CcSEcCtD
Cefotetan—Vomiting—Zoledronate—osteoporosis	0.000591	0.0019	CcSEcCtD
Cefotetan—Rash—Zoledronate—osteoporosis	0.000586	0.00188	CcSEcCtD
Cefotetan—Gastrointestinal pain—Estradiol—osteoporosis	0.000586	0.00188	CcSEcCtD
Cefotetan—Dermatitis—Zoledronate—osteoporosis	0.000585	0.00188	CcSEcCtD
Cefotetan—Vomiting—Conjugated Estrogens—osteoporosis	0.000569	0.00183	CcSEcCtD
Cefotetan—Urticaria—Estradiol—osteoporosis	0.000569	0.00183	CcSEcCtD
Cefotetan—Body temperature increased—Estradiol—osteoporosis	0.000566	0.00182	CcSEcCtD
Cefotetan—Abdominal pain—Estradiol—osteoporosis	0.000566	0.00182	CcSEcCtD
Cefotetan—Rash—Conjugated Estrogens—osteoporosis	0.000564	0.00181	CcSEcCtD
Cefotetan—Dermatitis—Conjugated Estrogens—osteoporosis	0.000564	0.00181	CcSEcCtD
Cefotetan—Nausea—Zoledronate—osteoporosis	0.000552	0.00177	CcSEcCtD
Cefotetan—Nausea—Conjugated Estrogens—osteoporosis	0.000532	0.00171	CcSEcCtD
Cefotetan—Hypersensitivity—Estradiol—osteoporosis	0.000528	0.00169	CcSEcCtD
Cefotetan—Pruritus—Estradiol—osteoporosis	0.000507	0.00163	CcSEcCtD
Cefotetan—Diarrhoea—Estradiol—osteoporosis	0.00049	0.00157	CcSEcCtD
Cefotetan—Vomiting—Estradiol—osteoporosis	0.000455	0.00146	CcSEcCtD
Cefotetan—Rash—Estradiol—osteoporosis	0.000452	0.00145	CcSEcCtD
Cefotetan—Dermatitis—Estradiol—osteoporosis	0.000451	0.00145	CcSEcCtD
Cefotetan—Nausea—Estradiol—osteoporosis	0.000425	0.00137	CcSEcCtD
Cefotetan—ALB—Platelet degranulation—WDR1—osteoporosis	0.000424	0.0441	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000404	0.042	CbGpPWpGaD
Cefotetan—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000403	0.0419	CbGpPWpGaD
Cefotetan—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000397	0.0412	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000388	0.0403	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—CAP1—osteoporosis	0.000335	0.0348	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000326	0.0338	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000319	0.0332	CbGpPWpGaD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000303	0.0315	CbGpPWpGaD
Cefotetan—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000264	0.0274	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—PLEK—osteoporosis	0.000244	0.0253	CbGpPWpGaD
Cefotetan—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000233	0.0242	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000232	0.0241	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TLN1—osteoporosis	0.00021	0.0218	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—VCL—osteoporosis	0.000207	0.0215	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.0002	0.0208	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.000197	0.0205	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000188	0.0195	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—FGA—osteoporosis	0.000157	0.0163	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000149	0.0155	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000149	0.0155	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—FGB—osteoporosis	0.000143	0.0148	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000137	0.0142	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000136	0.0141	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.00012	0.0125	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000118	0.0123	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—SOD2—osteoporosis	0.000111	0.0116	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000108	0.0112	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—GPX1—osteoporosis	0.000106	0.011	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—MTHFR—osteoporosis	9.8e-05	0.0102	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—WDR1—osteoporosis	9.69e-05	0.0101	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	9.31e-05	0.00968	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	9.18e-05	0.00955	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	8.84e-05	0.00919	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	8.44e-05	0.00877	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	7.79e-05	0.00809	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.71e-05	0.00802	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	7.67e-05	0.00798	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—CAP1—osteoporosis	7.66e-05	0.00796	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.31e-05	0.0076	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	7.15e-05	0.00743	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	6.96e-05	0.00723	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—IGF1—osteoporosis	6.46e-05	0.00672	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	6.33e-05	0.00658	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	6.16e-05	0.0064	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—MGLL—osteoporosis	6.09e-05	0.00633	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL1B—osteoporosis	5.82e-05	0.00605	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.69e-05	0.00591	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—PLEK—osteoporosis	5.57e-05	0.00579	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—ANXA2—osteoporosis	5.57e-05	0.00579	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.54e-05	0.00576	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	5.19e-05	0.00539	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	4.82e-05	0.00501	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TLN1—osteoporosis	4.8e-05	0.00499	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—VCL—osteoporosis	4.73e-05	0.00492	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	4.62e-05	0.0048	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.43e-05	0.0046	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—TNF—osteoporosis	4.22e-05	0.00439	CbGpPWpGaD
Cefotetan—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	4.19e-05	0.00435	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—RAP1A—osteoporosis	3.96e-05	0.00411	CbGpPWpGaD
Cefotetan—ALB—Platelet degranulation—TGFB1—osteoporosis	3.87e-05	0.00403	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.77e-05	0.00392	CbGpPWpGaD
Cefotetan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	3.69e-05	0.00384	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FGA—osteoporosis	3.59e-05	0.00373	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PKM—osteoporosis	3.44e-05	0.00357	CbGpPWpGaD
Cefotetan—ALB—Metabolism—FDPS—osteoporosis	3.44e-05	0.00357	CbGpPWpGaD
Cefotetan—ALB—Folate Metabolism—IL6—osteoporosis	3.41e-05	0.00354	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.35e-05	0.00348	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—FGB—osteoporosis	3.26e-05	0.00339	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PGLS—osteoporosis	3.26e-05	0.00338	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPD2—osteoporosis	3.26e-05	0.00338	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ATIC—osteoporosis	2.98e-05	0.0031	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PNP—osteoporosis	2.98e-05	0.0031	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.87e-05	0.00298	CbGpPWpGaD
Cefotetan—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.71e-05	0.00281	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CA2—osteoporosis	2.53e-05	0.00263	CbGpPWpGaD
Cefotetan—ALB—Metabolism—OXCT1—osteoporosis	2.53e-05	0.00263	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MGLL—osteoporosis	2.47e-05	0.00257	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.33e-05	0.00242	CbGpPWpGaD
Cefotetan—ALB—Metabolism—IDH2—osteoporosis	2.1e-05	0.00218	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP27A1—osteoporosis	1.97e-05	0.00205	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ACP5—osteoporosis	1.92e-05	0.002	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.9e-05	0.00197	CbGpPWpGaD
Cefotetan—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.81e-05	0.00188	CbGpPWpGaD
Cefotetan—ALB—Metabolism—TPI1—osteoporosis	1.78e-05	0.00185	CbGpPWpGaD
Cefotetan—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.72e-05	0.00179	CbGpPWpGaD
Cefotetan—ALB—Metabolism—P4HB—osteoporosis	1.68e-05	0.00174	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GAPDH—osteoporosis	1.65e-05	0.00171	CbGpPWpGaD
Cefotetan—ALB—Metabolism—RAP1A—osteoporosis	1.6e-05	0.00167	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—IGF1—osteoporosis	1.48e-05	0.00154	CbGpPWpGaD
Cefotetan—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.4e-05	0.00145	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ENO1—osteoporosis	1.3e-05	0.00135	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PSMA5—osteoporosis	1.28e-05	0.00133	CbGpPWpGaD
Cefotetan—ALB—Metabolism—PSMA2—osteoporosis	1.28e-05	0.00133	CbGpPWpGaD
Cefotetan—ALB—Metabolism—CYP19A1—osteoporosis	1.04e-05	0.00108	CbGpPWpGaD
Cefotetan—ALB—Hemostasis—TGFB1—osteoporosis	8.86e-06	0.000921	CbGpPWpGaD
Cefotetan—ALB—Metabolism—ADCY5—osteoporosis	8.47e-06	0.00088	CbGpPWpGaD
Cefotetan—ALB—Metabolism—GPX1—osteoporosis	8.44e-06	0.000877	CbGpPWpGaD
Cefotetan—ALB—Metabolism—MTHFR—osteoporosis	7.79e-06	0.00081	CbGpPWpGaD
Cefotetan—ALB—Metabolism—POMC—osteoporosis	6.23e-06	0.000647	CbGpPWpGaD
